Health & Biotech
Health & Biotech
Louie the beagle is beating the odds thanks to PharmAust’s canine cancer trial
Tech
Q&A: Nanoveu’s new chairman Dr David Pevcic says the market opportunity for antifouling solar panel coatings is in the billions
Health & Biotech
ASX Health Stocks: Mesoblast share price jumps as FDA accepts resubmission for Remestemcel-L
Health & Biotech
Broker says EZZ share price could more than double as the company makes inroads into global markets
Health & Biotech
As it awaits crucial FDA approval Botanix reckons Aussies have a penchant for backing high-risk companies
Health & Biotech
PharmAust eyes Phase-3 trial after positive results from canine cancer drug
Health & Biotech
ASX Health Stocks: Emyria partners with Pax Centre to provide psychedelics therapy for PTSD sufferers
Health & Biotech
Dr Boreham’s Crucible: Tag it and bag it – Bluechiip’s ready to come in from the cold
Health & Biotech
Argenica confirms safety of ARG-007 in Phase-1 trial, makes preparations for Phase-2
Health & Biotech
ASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTAT
Health & Biotech
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but keep watchful eye on upcoming catalysts
Health & Biotech
Incannex commences manufacture of psilocybin for trials and commercial applications
Health & Biotech
ASX Health Stocks: AFT Pharma wins crucial US FDA approval for Maxigesic pain tablets
Health & Biotech
PharmAust’s interim analysis could set the stage for expedited Phase-2 MND trial
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.